Invention Application
US20120316135A1 Compounds for Inhibiting Cell Proliferation in EGFR-Driven Cancers
有权
用于抑制EGFR驱动的癌细胞增殖的化合物
- Patent Title: Compounds for Inhibiting Cell Proliferation in EGFR-Driven Cancers
- Patent Title (中): 用于抑制EGFR驱动的癌细胞增殖的化合物
-
Application No.: US13464921Application Date: 2012-05-04
-
Publication No.: US20120316135A1Publication Date: 2012-12-13
- Inventor: David C. Dalgarno , Wei-Sheng Huang , William C. Shakespeare , Yihan Wang , Xiaotian Zhu
- Applicant: David C. Dalgarno , Wei-Sheng Huang , William C. Shakespeare , Yihan Wang , Xiaotian Zhu
- Applicant Address: US MA Cambridge
- Assignee: ARIAD Pharmaceuticals, Inc.
- Current Assignee: ARIAD Pharmaceuticals, Inc.
- Current Assignee Address: US MA Cambridge
- Main IPC: A61K31/675
- IPC: A61K31/675 ; C07F9/6558 ; C12N5/09 ; C07F9/6561 ; A61P35/00 ; C12N5/071 ; C07F9/6512 ; C07F9/6509
Abstract:
The invention features compounds, pharmaceutical compositions and methods for treating patients who have an EGFR-driven cancer of formula I: wherein the variables are as defined herein.
Public/Granted literature
- US09834518B2 Compounds for inhibiting cell proliferation in EGFR-driven cancers Public/Granted day:2017-12-05
Information query
